PATENT CLAIM ANALYSIS

Application Number: 15954693
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "450000"]

Abstract:
The invention provides for the use of protein kinase activators or boosters of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) or other neurotrophic factors to treat head trauma. Specifically, the present invention provides methods of treating head trauma comprising the steps of identifying a subject having suffered a head trauma and administering to said subject an amount of a pharmaceutical composition comprising a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) and a pharmaceutically acceptable carrier effective to treat at least one symptom of head trauma.

Claim (Index 33):
The method of  claim 22 , wherein said administration is initiated within 1, 2, or 3 days of said head trauma.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.62903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12068742', '13178843', '14818576', '13817040', '13669353']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.742722108725042
- 35 USC 102 Novelty (BERT): 0.6016822331035667
- Combined Prediction Score: 0.7286181211628945
- Mean Citation Score: 333.99110400000006
- Max Citation Score: 536.6984
- Similarity Product: 462.60503197393416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test